Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 9.777.319.1710.9810.29

What is the latest Core EBITDA Margin ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Margin ratio of AUROBINDO PHARMA is 9.77 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20249.77
Mar20237.31
Mar20229.17
Mar202110.98
Mar202010.29

How is Core EBITDA Margin of AUROBINDO PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 9.77
33.65
Mar2023 7.31
-20.28
Mar2022 9.17
-16.48
Mar2021 10.98
6.71
Mar2020 10.29 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Margin ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses